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Reactive oxygen species rescue 
regeneration after silencing 
the MAPK–ERK signaling pathway 
in Schmidtea mediterranea
V. Jaenen1, S. Fraguas2,3, K. Bijnens1, M. Heleven1, T. Artois1, R. Romero2, K. Smeets1,4,5* & 
F. Cebri 2,3,5*
Despite extensive research on molecular pathways controlling the process of regeneration in model 
organisms, little is known about the actual initiation signals necessary to induce regeneration. 
Recently, the activation of ERK signaling has been shown to be required to initiate regeneration in 
planarians. However, how ERK signaling is activated remains unknown. Reactive Oxygen Species 
(ROS) are well-known early signals necessary for regeneration in several models, including planarians. 
Still, the probable interplay between ROS and MAPK/ERK has not yet been described. Here, by 
interfering with major mediators (ROS, EGFR and MAPK/ERK), we were able to identify wound-
induced ROS, and specifically  H2O2, as upstream cues in the activation of regeneration. Our data 
demonstrate new relationships between regeneration-related ROS production and MAPK/ERK 
activation at the earliest regeneration stages, as well as the involvement of the EGFR-signaling 
pathway. Our results suggest that (1) ROS and/or  H2O2 have the potential to rescue regeneration after 
MEK-inhibition, either by  H2O2-treatment or light therapy, (2) ROS and/or  H2O2 are required for the 
activation of MAPK/ERK signaling pathway, (3) the EGFR pathway can mediate ROS production and 
the activation of MAPK/ERK during planarian regeneration.
Regeneration is the fascinating phenomenon in which animals repair and regrow lost or damaged tissues, struc-
tures or even the whole  body1. At the cellular level, this includes processes such as proliferation, migration and 
differentiation; all of them needed to be under a strict genetic and molecular  control2. The capacity to regenerate 
is widely distributed across the animal  kingdom3. However, the level of regeneration varies significantly among 
different species; from full-body regeneration in invertebrates such as Hydra and planarians to regeneration 
of specific organs and structures such as limbs in amphibians and the heart in  zebrafish4–6. Mammals such as 
humans, on the other hand, have minimal regenerative capabilities. Understanding how tissue development takes 
place in model organisms might provide fundamental knowledge for the further improvement of regenerative 
medicine.
In this context, freshwater planarians are a model with several attractive features: (1) they can regenerate a 
whole body from a tiny piece, (2) a large part of their cells consists of a population of adult pluripotent stem cells 
called neoblasts, with a similar transcriptional profile as compared with other invertebrate and vertebrate stem 
 cells7,8 and (3) they use conserved signaling pathways to regulate cell differentiation, patterning and morphogen-
esis. Thus, Hedgehog and Wnt/β-catenin signaling are required to re-establish the antero-posterior axis of the 
animal, the BMP pathway regulates the dorsoventral axis, and the EGFR pathway is needed for proper neoblast 
 differentiation9–13. Although several studies have uncovered a pivotal role of these, and other, signaling pathways 
during planarian regeneration, little is known about which upstream signals activate them in order to trigger a 
regenerative answer after amputation. Recently, Owlarn and colleagues reported that a planarian extracellular 
signal-regulated protein kinase (ERK) is strongly activated in a stem cell-independent manner, just minutes 
after  amputation14. By inhibiting protein synthesis using cycloheximide, they showed that ERK activation is 
triggered by injury signals that do not originate from newly synthesized proteins. Therefore, ERK activation by a 
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still unknown factor appears to be the most upstream initiator of planarian  regeneration14. In recent years, many 
in vitro as well as in vivo studies put forward reactive oxygen species (ROS) as upstream signaling molecules of 
 regeneration15–17.  H2O2, for example, can cross cell membranes through aquaporin channels and gap-junctions 
and diffuse freely between the  cells18,19. Similar to what happens in other physiological processes such as growth, 
inflammation and ageing, wound-induced ROS, and especially the non-radical ROS,  H2O2, with its rather long 
half-life, can play a regulating role in early wound responses and regeneration. In 2013, Love et al. demonstrated 
that amputation-induced ROS production is required for tadpole tail regeneration in Xenopus20. Shortly after, 
Gauron and colleagues showed a similar ROS production at the amputation site during fin regeneration in adult 
zebrafish and proved its role in blastema  formation21. More recently, the Serras laboratory demonstrated the 
presence of an oxidative burst just minutes after inducing regeneration of the wing imaginal disc in Drosophila22. 
Also, in planarians, we reported that an amputation-induced ROS burst is necessary for proper stem cell dif-
ferentiation and successful  regeneration17.
Many studies have already shown an interplay between ROS and mitogen-activated protein kinases (MAPK) 
signaling  pathways23,24. Ruffels et al. simulated a ROS burst by direct exposure of exogenous  H2O2 to human 
neuroblastoma cells, resulting in a significant increase in ERK  activation25. In Drosophila, ROS-dependent 
stimulation of MAPKs is essential for the activation of JAK/STAT signaling, which drives  regeneration22. In 
 planarians26 and other  models27–29, the activation of MAPK pathways can be mediated by the upstream epider-
mal growth factor receptor (EGFR), and also the activation of the EGFR pathway by ROS has been described 
in different  models30,31. Overall, these studies suggest that wound-induced ROS signaling may operate through 
EGFR–MAPK pathways, stimulating transcriptional expression of regeneration-related genes, crucial for tissue 
repair and restoration of homeostasis.
Even though ROS, EGFR and ERK are required for planarian regeneration, the relationship between these 
pathways is not known. Here, we show that amputation-induced ROS production might be the upstream cue 
that activates ERK signaling to initiate regeneration.
Results
Generation of reactive oxygen species after applying an R- or H-wound. In planarians, a common 
generic wound response program is triggered by either injuries that require only wound healing (H-wounds) 
or by injuries that imply tissue loss and therefore require regeneration (R-wounds)14. We previously showed an 
amputation-induced ROS burst after inflicting an R-wound in planarians plus regenerative defects when inhibit-
ing this ROS burst by DPI  treatment17. Here we confirm the impaired regeneration after inhibition of ROS pro-
duction (Supplementary Fig. S1) as well as the fast ROS production at the R-wound site, and additionally show 
the ROS burst after inflicting an H-wound (Fig. 1a, Carboxy-H2DCFDA, green signal). Furthermore, because 
carboxy-H2DCFDA is used to stain all intracellular ROS, in which a distinction between the different species 
cannot be made, we additionally visualized  H2O2 specifically by the aid of PO1 (Peroxy Orange 1). A clear fluo-
rescent signal at both R- and H-wound sites (Fig. 1a, PO1, orange signal) is observed, indicating a significant 
production of  H2O2 after inflicting a wound.
Owlarn and colleagues showed that MEK inhibition blocks regeneration. These MEK-inhibited fragments 
remain in a dormant non-regenerative state unless novel R- or H-wounds are inflicted in the dormant wound site. 
Both wound types trigger generic initiation signals, resulting in the re-activation of the regeneration  program14. 
Furthermore, we demonstrated that not only a H-wound inflicted in the dormant wound site, but also more 
distant wounds were able to rescue regeneration in MEK-inhibited tails at very similar levels based on blastema 
size and eye development. Moreover, and in accordance with the results of Owlarn et al., the level of rescue was 
proportional with the amount of wounding, (Supplementary Fig. S2c). These results suggest that the generi-
cally induced initiation signals could possibly communicate with the dormant blastema in order to re-initiate 
regeneration.
In order to check if these initiation signals could possibly be ROS/H2O2, we first verified their presence at the 
wound site directly after re-wounding MEK-inhibited fragments. Both, general ROS and  H2O2 were detected at 
the site of the newly inflicted R- and H-wounds in the MEK-inhibited fragments (Fig. 1b, upper panels). After 
inflicting an H-wound, ROS levels did not only increase at the H-wound site, but also occurred at the original, 
R-wound site (Fig. 1b, lower panel, red arrowhead). Treatment with DPI (Diphenyleneiodonium; a nonspe-
cific flavoprotein inhibitor interfering with many different electron transporters, widely used as ROS inhibitor) 
resulted in a robust decrease of ROS/H2O2-signals at all wound sites (Fig. 1c). Quantification of the fluorescence 
intensity confirmed the statistically significant decrease in ROS production (general ROS and  H2O2) at the 
newly inflicted R- or H-wound in MEK-inhibited tails after treatment with DPI (Fig. 1d). Correspondingly, a 
significant decrease in regeneration was observed when combining a new R-wound in MEK-inhibited tails with 
treatment with DPI (Supplementary Fig. S2b). Negative controls (without carboxy-H2DCFDA or PO1) showed 
no autofluorescence at both R- and H-wound sites (Supplementary Fig. S3). All together, these results point out 
that the fast-developing wound-induced ROS burst, and more specifically  H2O2, could act as an upstream key 
mediator in both initiating and rescuing regeneration.
Hydrogen peroxide treatment rescues regeneration in dormant MEK-inhibited fragments. To 
functionally confirm a role for ROS as a regeneration initiating signal, we investigated if we could reactivate 
MEK-inhibited, dormant blastemas by treating them with exogenous ROS. Because of the fact that it is present 
at the wound site post amputation, its vital role in regeneration and the supporting evidence for its activating 
role in several molecular pathways, we used the non-radical ROS,  H2O2, as exogenous ROS-source and pos-
sible regeneration initiating signal (Fig. 2). When inflicting a new R-wound (Fig. 2b: REcut) to MEK-inhibited 
trunk fragments (with pharynx), 96.88% (n = 32) of the fragments regenerated. A small fraction of these ani-
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Figure 1.  In vivo visualization of ROS production at the amputation site after re-wounding MEK-inhibited 
dormant fragments. For each condition, the experimental setup is displayed in the left panel. Color code as 
follows; green: MEK inhibition by PD0325901 (10 μM, 5 days), red: inhibition of ROS production by DPI 
(3 μM, 5 h), blue: ROS visualization procedure using carboxy-H2DCFDA as general ROS indicator or peroxy-
orange-1 to specifically stain  H2O2, yellow: imaging. Regenerative wound (R-wound) and healing wound 
(H-wound). All animals were imaged 30 min post amputation (MPA). A representative close-up merged image 
of bright field and fluorescence of either R-wounds or H-wounds after the general ROS stain is displayed on 
the left panel (green fluorescence), and a close-up image of the specific  H2O2 stain is displayed on the right 
(orange fluorescence) (a) ROS production at the site of an R-wound and an H-wound in controls. (b) ROS 
production at the amputation site of an R-wound and an H-wound in MEK-inhibited (PD0325901), dormant 
fragments. Lower panel in (b) shows an image of the site of the original R-wound applied before MEK-
inhibition (red arrowhead) together with the newly applied H-wound (red square). (c) ROS production after 
re-wounding (R-wound and H-wound) MEK-inhibited and DPI exposed dormant fragments. Because of the 
strongly reduced fluorescence in (c), the close-up of the wound site is shown in bright field (upper left panels) 
and fluorescence (lower left panels) separated for in the general ROS stain while the  H2O2 stain allows to only 
display the fluorescence images (on the right panels). The dotted, white lines indicate the border of the wound 
site. Scale bars 100 µm. (d) Relative fluorescence intensity of the wound region. Color code as follows; dark 
blue: control (representing data of panel A), light blue: MEK inhibition (representing data of panel B), yellow: 
MEK inhibition + DPI (representing data of panel c). Left panel; fluorescence intensity representing general 
ROS production visualized with carboxy-H2DCFDA. Right panel; fluorescence intensity representing hydrogen 
peroxide production visualized with peroxy orange 1 (PO1). Statistical significance is indicated by: *p < 0.05; 
**p < 0.01; ***p < 0.001.
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Figure 2.  H2O2 treatment rescues regeneration in MEK-inhibited dormant fragments. (a) For each condition 
indicated above, the experimental setup is displayed. Color code as follows; green: MEK inhibition by 
PD0325901 (10 μM,5 days), blue: recovery in fresh medium after several washes (1 day), red: treatment with 
 H2O2 (1.5–2.25 mM, 6 h), yellow: follow up in fresh medium after several washes (7 days). (b) Dormant MEK-
inhibited trunk fragments with pharynx and (c) tail fragments without pharynx were “REcut” or treated with 
exogenous  H2O2 (“NO REcut + H2O2”). “NO REcut” controls were neither recut or treated with  H2O2 and were 
only MEK-inhibited. (b/c, upper panel) Graph displaying the percentage of different regenerative outcomes. 
Sample numbers are indicated in each graph and represent 4 independent experiments. The legend associated 
with these graphs: no regeneration (white), reduced regeneration (light blue), normal regeneration (dark blue) 
and dead (black). “Normal regeneration” is considered as full regeneration including both eyes, and if needed 
pharynx. In the case of “reduced regeneration”, a clear blastema was visible, however, no or one eye(s) and/or 
no pharynx were differentiated at this time point. “No regeneration” refers to the absence of a blastema and a 
total block of regeneration. Scale bars 100 µm. (b/c, lower left panel) Relative blastema sizes in each condition. 
Statistical significance is indicated by: *p < 0.05; **p < 0.01; ***p < 0.001. (b/c, lower middle panel) Appearance 
of the eyes. Left bar (green): two eyes; middle bar (light green): 1 eye; right bar (red): no eyes. These graphs 
represent results of 3 independent experiments with 24 (REcut), 35 (NO REcut) & 56 (NO REcut + H2O2) 
biological replicates for the setup using tails with a pharynx (b) and 20 (REcut), 36 (NO REcut) and 38 (NO 
REcut + H2O2) for the setup using tails without a pharynx (c). (b/c, lower right panel) The amputation setup; 1st 
cut applied 1 h after incubation in 10 μM PD0325901 followed by 5 days in the same solution, “REcut” applied 
after recovery period and only applicable in the “REcut” condition). All measurements were carried out 7 days 
post re-wounding or  H2O2 treatment.
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mals (6.25%) started regenerating but experienced a reduced eye development at the moment of comparison. 
In the absence of a new R-wound (Fig. 2b: NO REcut), 91.67% (n = 60) of the MEK-inhibited trunks failed to 
regenerate, while the remaining part regenerated a smaller blastema. In tail fragments (without a pharynx), 
100% (n = 30) restarted regeneration after inflicting an R-wound, of which 96.67% regenerated normally while 
the remaining part failed to regenerate both eyes and/or pharynx (Fig. 2c: REcut). Without inflicting a new 
R-wound, 95% (n = 80) of the fragments did not regenerate and in 5% regeneration was impaired (Fig. 2c: NO 
Recut). In all “NO Recut” cases of both setups, the absence of regeneration remained for at least 21 days. Initial 
dose–response experiments indicated that a 6-h treatment with 1.5 to 2.25 mM  H2O2 was enough to fully rescue 
26.76% (n = 120) of the MEK-inhibited trunk fragments (with pharynx), and 5% (n = 80) of MEK-inhibited 
tail fragments (without pharynx) in the absence of re-amputation. An additional 20.83% of the trunk frag-
ments were partially rescued, showing an impaired regeneration. In case of the tail fragments this partial rescue 
reached 28.75% (Fig. 2b/c: NO REcut + H2O2). In both setups, a small number of animals died, being 6.58% 
and 13.75% for respectively trunk and tail fragments. We quantified the rescue in regeneration after  H2O2 treat-
ment by measuring the blastema relative to the whole fragment.  H2O2 treatment after MEK-inhibition led to 
significantly bigger blastema sizes compared to MEK-inhibited regenerating fragments without such treatment. 
Furthermore, recutting dormant fragments led to significantly bigger blastemas compared to the  H2O2-treated 
and the MEK-inhibited fragments without further treatment (Fig. 2b/c). The same trends were observed for the 
differentiation of new eyes (Fig. 2b/c).
In order to exclude that the observed rescue was induced by tissue wounding as a result of the  H2O2 treatment, 
a ROS staining was performed on dormant fragments after 3 and 6 h of exposure to  H2O2. The epidermis main-
tained its integrity, at least at the morphological level. Neither epidermal wounds, nor ROS signals were observed 
in these  H2O2-treated planarians (Supplementary Fig. S4). Taken together, these results show the probable role of 
 H2O2 as an upstream regeneration-initiation signal and its ability in rescuing dormant MEK-inhibited fragments.
Light therapy rescues regeneration in dormant MEK-inhibited fragments. Light or photomodu-
lation therapy (LT) is broadly applied in certain pathologies to stimulate wound healing and stem cell activity. 
Several publications associated this stem cell stimulation with a therapy-induced ROS production, activating 
underlying signaling  pathways32–37. We investigated the possibility of rescuing dormant MEK-inhibited frag-
ments by an indirect way of ROS production, in this case light therapy. As already confirmed in Fig. 2b, recutting 
MEK-inhibited trunk fragments led to a full regeneration in the majority of the fragments (98.75%; n = 80), 
while in the absence of a new R-wound the fragments remained dormant (88.89%; n = 72) (Fig. 3b: REcut and 
NO REcut). On the other hand, treating dormant, MEK-inhibited fragments with light therapy was sufficient 
to rescue regeneration in 32.09% of them from which 21.09% fully regenerated (n = 128). The other 67.97% was 
not able to regenerate (Fig. 3b: NO Recut + LT). The extent of this rescue was quantified by measuring blastema 
size with respect to the size of the whole fragment. Remarkably, light therapy after MEK-inhibition led to sig-
nificantly bigger blastemas compared with blastemas from MEK-inhibited regenerating fragments without any 
treatment. Re-cutting dormant fragments led to significantly bigger blastemas compared with the light treated 
ones as well as the MEK-inhibited fragments without any treatment. The same trends were observed for the dif-
ferentiation of the eyes (Fig. 3b).
To test the assumption of ROS as a possible underlying mechanism in rescuing regeneration in MEK-inhibited 
fragments, an in vivo general ROS staining was carried out after the light therapy. A total of 30% (n = 12) of 
the fragments treated with light therapy presented a clear ROS production at the original, dormant, R-wound 
site while a slight ROS production was visualized in the rest of the body (Fig. 3c, left panels, red arrowhead). 
Strongly corresponding results were obtained after conducting the more specific in vivo  H2O2 stain. In roughly 
35% (n = 17) a clear  H2O2 production was visible at the original R-wound after applying light therapy (Fig. 3c, left 
panels, red arrowhead). The percentage of fragments displaying a clear ROS/H2O2 production is in accordance 
with the percentage of animals in which regeneration was rescued after light therapy (Fig. 3b: LT). To confirm 
that the ROS production at the original R-wound site was induced by light therapy, a ROS staining (general ROS 
and  H2O2) was performed on dormant fragments without light treatment. In this condition, no ROS or  H2O2 
production was observed in any planarian (general ROS: n = 9,  H2O2: n = 13) (Fig. 3c, control). Quantification 
of the fluorescent signal showed a statistically significant increase in both ROS and  H2O2 production induced 
by light therapy (Fig. 3c, right panels). Additionally, temperature of the medium was measured before and after 
applying the light therapy. This was performed in order to exclude that the rescue was not induced by oxidative 
stress caused by the heating up of the medium in which the MEK-inhibited fragments were put during the light 
therapy. Before and after the light therapy the medium was exactly at the same temperature of 18 °C. Supple-
mentary Figure S5a displays a possible mechanism by which ROS can be produced after applying light therapy. 
Stubenhaus and colleagues proposed this model in which porphyrin, present in pigment cells, produces ROS after 
photomodulation, which in turn can activate intracellular signaling cascades or diffuse out of the cell and trigger 
surrounding cells  instead36,37. Directly after applying light therapy, worms started to depigment. The depigmenta-
tion increased over time. This can be observed in supplementary Fig. S5b when comparing the pigmentation level 
on day 4 and day 7 post light therapy (DPLT). With these results we point out the possibility of photomodulation-
induced rescue of MEK-inhibition and subsequent rescue of regeneration. We hypothesize ROS production after 
applying light therapy, as underlying mediator, functioning to (re)stimulate stem cell activity.
Inhibition of ROS production blocks ERK activation at the wound site. To identify whether in 
normal conditions the amputation-induced ROS production is required for the activation of the ERK signaling 
pathway, we performed an immunostaining with anti-pERK antibody after ROS inhibition by  DPI26,38. When 
animals were kept in regular medium or DMSO, a clear activation of pERK was observed at the wound site of 
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Figure 3.  Light therapy rescues regeneration in MEK-inhibited dormant fragments. (a) For each condition the 
experimental setup is displayed. Color code as follows; green: MEK inhibition (PD0325901, 10 μM, 5 days), blue: 
recovery in medium (1 day), red: light therapy (VIS light, 3 h; 1 h light-1 h dark-1 h light), yellow: follow up in 
medium (7 days). (b) Dormant MEK-inhibited trunk fragments with pharynx were “REcut” or treated with light 
therapy “LT”. “NO REcut” controls were neither recut or treated with light therapy and were only MEK-inhibited. 
(b, upper panel) Graph displaying the percentage of different regenerative outcomes. Sample numbers are indicated 
in each graph and represent 5 independent experiments. At the upper right, the legend associated with the graph: 
no regeneration (white), reduced regeneration (light blue), normal regeneration (dark blue). “Normal Regeneration” 
is considered as full regeneration including both eyes. In the case of “Reduced Regeneration”, a clear blastema was 
visible, however, no or one eye(s) were differentiated at this time point. “No Regeneration” refers to the absence 
of a blastema and a total block of regeneration. Scale bars 100 µm. (b, lower left panel) Relative blastema sizes 
per condition. Statistical significance is indicated by: *p < 0.05; **p < 0.01; ***p < 0.001. (b, lower middle panel) 
Appearance of the eyes. Left bar (green): two eyes; middle bar (light green): 1 eye; right bar (red): no eyes. This graph 
represents the same samples as used to measure the blastemas. (b, lower right panel). The amputation setup;  1st 
cut applied 1 h after incubation in 10 μM PD0325901 followed by 5 days in the same solution,  2nd cut applied after 
the recovery period and only applicable in the “REcut” condition. All measurements were carried out 7 days post 
rewounding or light therapy. (c, left panels) in vivo ROS stain (Carboxy-H2DCFDA: general ROS, PO1: hydrogen 
peroxide) after conducting light therapy on MEK-inhibited tails. Controls were stained after the recovery period, 
without light therapy while treated samples were directly stained after light therapy. A clear ROS production (general 
ROS + hydrogen peroxide) was visualized after light therapy, at the original R-wound applied before MEK-inhibition 
(red arrowhead). Sample numbers are indicated in the images. All pictures were taken under the same light 
intensity settings. The dotted, white lines indicate the border of the wound site. Scale bars 100 µm. (c, right panels) 
Relative fluorescence intensity at the original R-wound region. Upper graph indicates relative fluorescence intensity 
representing general ROS production. Lower graph indicates relative fluorescence intensity representing hydrogen 
peroxide production. Statistical significance is indicated by: *p < 0.05; **p < 0.01; ***p < 0.001.
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head- (control: 4/5, DMSO: 3/6), trunk- (control: 6/7, DMSO: 6/8) as well as tail pieces (control: 4/6, DMSO: 
4/6). This pERK-signal was strongly reduced when fragments were treated with DPI (heads: 5/7, trunks: 7/9, 
tails: 5/7) (Fig. 4b). After quantification of the signal attributed to activated ERK, statistical significance was 
obtained between both control conditions (medium and DMSO) and ROS inhibited trunks as well as between 
control- (medium) and ROS-inhibited tails (Fig. 4c). Despite no other significant difference, a strong trend was 
visible between both control conditions (medium and DMSO) and ROS-inhibited fragments of either heads, 
trunks or tails. Taken together, these data suggest that an amputation-induced ROS production at the wound site 
is required for the phosphorylation and proper activation of ERK.
Smed‑egfr‑3 silencing impairs ROS production at the wound site. In literature, many examples 
exist of the activation of the epidermal growth factor receptor (EGFR) signaling by ROS and the role of EGFR in 
mediating MAPK signaling including ERK  activation26–31,39,40. To further characterize the relationship between 
ROS and the EGFR/MAPK signaling during planarian regeneration, an in vivo ROS visualization was performed 
in controls and animals subjected to RNAi-mediated silencing of Smed-egfr-3 (Fig. 5). Whereas the presence of 
the amputation-induced ROS burst was clear in the control animals (30MPA: 5/7, 6HPA: 7/8, 1DPA: 6/8), trunk 
fragments subjected to Smed-egfr-3 knockdown showed a clearly diminished ROS production at all time points 
(30MPA: 6/7, 6HPA: 5/7, 1DPA: 5/7) (Fig. 5c). Quantification of the fluorescence intensity confirmed the sta-
tistically significant decrease in ROS production after knocking down Smed-egfr-3 (Fig. 5d). These results indi-
cate that Smed-egfr-3 might play a pivotal role in regulating the amputation-induced ROS production, possibly 
through the existence of a feedback mechanism. Furthermore, it is suggested that the activation of pERK by ROS 
could be mediated by the EGFR pathway during regeneration.
Figure 4.  pERK activation decreases after the inhibition of ROS production (a) The amputation setup is 
displayed in the light blue box, indicating the amputation sites. (b) Immunostaining with an anti-pERK 
antibody on 1-day regenerating fragments. Animals kept in culture medium or 0.01% (v/v) DMSO were used as 
control animals, while in the treatment group, ROS production was inhibited with DPI (3 μM) administered in 
the culture medium during regeneration. All pictures were taken under the same light intensity settings. Sample 
numbers are indicated in the images. Scale bars 100 µm. (c) Relative fluorescence intensity of the blastema 
region. Setup of the measurement is indicated in the upper panel while the mean relative fluorescence intensity 
is displayed in the graph below. Color code as follows; dark blue: control in culture medium, light blue: control 
in 0.01% DMSO, yellow: 3 μM DPI. Statistical significance is indicated by: *p < 0.05; **p < 0.01; ***p < 0.001.
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In addition, we explored the possibility of aquaporins functioning as  H2O2 transporter, playing an essential 
role in redox-related activation of the Smed-egfr-3/MAPK pathway. Seven planarian aquaporins were identified 
and co-expression with ERK, EGFR-3 and some of these aquaporins were observed in neoblasts, neurons and 
epidermal cells after in silico analysis. However, no regeneration defects were observed after knocking down the 
individual aquaporins (Supplementary Fig. S6 and S7).
Knocking down Smed‑egfr‑3 diminishes pERK activation in regenerating animals. In planari-
ans, silencing Smed-egfr-3 results in impaired regeneration with impaired stem cell  differentiation30. In addition, 
previous results suggested a relationship between Smed-egfr-3 and ERK  activation26. To further investigate the 
functional relationship between Smed-egfr-3 and pERK, we carried out an immunostaining with the anti-pERK 
antibody in controls and RNAi-mediated Smed-egfr-3 knockdown animals (Fig. 6a). A clear pERK activation 
was observed in all control fragments (Fig. 6b, trunk pieces: 7/11, tail pieces: 5/5). In contrast, a strong reduction 
of the anti-pERK signal at the wound site was detected in Smed-egfr-3 silenced fragments (Fig. 6b, trunk pieces: 
7/8, tail pieces: 5/7). After quantification of the fluorescent signal indicating activated ERK, statistical signifi-
cance was determined between controls and Smed-egfr-3 knockdown trunk pieces. Despite no other significant 
difference, the same trend was observed between controls and Smed-egfr-3-RNAi tail pieces (Fig. 6c).
To check whether Smed-egfr-3 and Smed-erk are indeed expressed in the same cell types, we analyzed the 
expression of these two genes at the single cell level at the online resource at digiworm.wi.mit.edu41 and used 
the tools in  PlanExp42 to visualize their co-expression. Smed-egfr-3 and Smed-erk are co-expressed in a variety 
of cell types including neoblasts, neurons, epidermis and pharyngeal cells (Fig. 6d). Overall these results sug-
gest that Smed-egfr-3 could work as an upstream factor for the activation of ERK. In Fig. 6e we summarized the 
interactions between ROS and the Smed-egfr-3/MAPK pathway, based on all results presented in this paper and 
supplemented with literature.
Figure 5.  ROS production is regulated by Smed-egfr-3 during early regeneration. (a) The amputation setup 
is displayed in the grey box, indicating the amputation sites. The red square corresponds to the images shown 
in (c). (b) The experimental setup is displayed in the light grey panel. Color code as follows; green: Smed-egfr3 
RNAi (2 rounds of 3 consecutive days), blue: recovery in fresh medium (4 days), red: general ROS stain using 
carboxy-H2DCFDA, yellow: imaging procedure. (c) In vivo visualization of amputation-induced ROS levels 
30 min-, 6 h- and 1 day post amputation (MPA, HPA, DPA) in controls and Smed-egfr-3 RNAi fragments. All 
pictures were taken under the same light intensity settings. Sample numbers are indicated in the images. Scale 
bar 100 µm. (d) Relative fluorescence intensity of the wound region. Color code as follows; dark blue: control, 
yellow: Smed-egfr-3 (RNAi). Statistical significance is indicated by: *p < 0.05; **p < 0.01; ***p < 0.001.
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Discussion
The complex process of animal regeneration is highly organized and regulated by a tightly controlled network of 
signaling pathways, of which we have only discovered the tip of the iceberg. Regeneration research has mainly 
focused on deciphering the molecular mechanisms regulating cell fate, polarity re-establishment, tissue dif-
ferentiation and organ positioning; however, the question on which initial signals trigger regeneration remains 
poorly understood. In recent years, several studies have reported the indispensability of reactive oxygen species 
(ROS) during regeneration. Amputation-induced ROS production was observed in early tail regeneration of 
Xenopus tadpoles and in fin regeneration of adult  zebrafish20,21. Similar observations were reported during the 
Figure 6.  Smed-egfr-3 is required for pERK activation. (a) The amputation setup is displayed in the light 
blue box, indicating the amputation sites. Red squares correspond to the anterior blastemas shown in B (b) 
Immunostaining with an anti-pERK antibody in controls and after Smed-egfr-3 RNAi at 1 day post-amputation. 
All pictures were taken under the same light intensity settings. Sample numbers are indicated in the images. 
Scale bars 100 µm. (c) Relative fluorescence intensity of the blastema region. Setup of the measurement is 
indicated in the upper panel while the mean relative fluorescence intensity is displayed in the graph below. Color 
code as follows; dark blue: control, yellow: Smed-egfr3 RNAi. Statistical significance is indicated by: *p < 0.05; 
**p < 0.01; ***p < 0.001. (d) Expression and co-expression of Smed-erk and Smed-egfr-3 based on single cell 
sequencing  available41,42. For each of the lineages analyzed in each graph the first column represents the number 
of cells of that particular lineage in which neither Smed-egfr-3 nor Smed-erk are expressed. The second column 
indicates the number of cells expressing Smed-erk. The third column indicates the number of cells expressing 
Smed-egfr-3. Finally, the fourth column indicates the number of cells in which Smed-egfr-3 and Smed-erk are 
co-expressed. (e) A possible regulatory pathway implicating ROS, Smed-EGFR-3, MEK and ERK is displayed 
based on literature and the results presented here.
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regeneration process of the wing imaginal disc in Drosophila and during regeneration of the planarian Schmid-
tea mediterranea17,22. In all of the above-mentioned cases, ROS production was clearly linked to the capacity 
to regenerate, e.g. diminished ROS production during regeneration-initiation led to regenerative impairments 
(Supplementary Fig. S1)14,17,20–22.
In a previous study we demonstrated the use of two different ROS-inhibiting compounds in S. mediterranea, 
i.e. DPI and  APO17. Both drugs are widely used in in vitro models as well as in vivo regeneration models. In 
S. mediterranea, DPI-induced effects were more severe in comparison with APO-related defects, which could 
be explained by their substrate specificity. While APO specifically blocks NOX-like enzymes, DPI targets both 
extracellular membrane-associated as well as mitochondrial flavoproteins causing a stronger decrease in ROS 
production and consequently inducing more severe regeneration  defects43–45. Therefore, we used DPI to further 
analyze the functional role of ROS during planarian regeneration. Off-target effects of DPI were taken into 
account as also other approaches were used to interfere with the redox state, such as light therapy. In addition 
to the ROS burst observed at the wound site after inflicting a regenerative(R)-wound17, our current data also 
show ROS production after inflicting a healing(H)-wound (Fig. 1a). In both cases, the ROS burst was shown via 
a general oxidative stress indicator (Carboxy-H2DCFDA), and a more specific one (Peroxy Orange 1) to show 
that  H2O2 is amongst the reactive oxygen species produced (Fig. 1). PO1 is new for planarian research but is 
extensively used in in vitro as well as in vivo models and is, just as carboxy-H2DCFDA, specific for the detection 
of intracellular  species46–48. False positives cannot be completely excluded after the use of in vivo ROS stainings, 
but both DPI and APO strongly decreased the ROS signal and induced similar results in the exposed planarians. 
Owlarn and colleagues have described that both R-wounds and H-wounds trigger a common initial molecular 
response mediated by ERK signaling. Inhibition of the ERK upstream activator, MAPK/ERK kinase (MEK), 
completely blocks regeneration after an R-wound14. The body fragments remain “dormant” until a new R- or 
H-wound is made, which somehow re-activates the regeneration program. The fact that inflicting a new H-wound 
elsewhere is capable of rescuing regeneration at the original dormant R-wound suggests that, in planarians, any 
kind of wounding (whether or not it results in tissue loss) triggers an early response through ERK  activation14. In 
the current study, we observed a fast production of ROS, and  H2O2 in specific, in these MEK-inhibited dormant 
fragments after inflicting a new H- or R-wound (Fig. 1b). Surprisingly, H-wounding in the flank not only induced 
ROS production at the applied H-wound site but also at the original, dormant R-wound site (Fig. 1b). Together 
with the results of (1) a significant rescue of regeneration at the dormant, MEK-inhibited R-wound site when 
applying an H-wound elsewhere and (2) a blocked rescue of regeneration when combining the re-wounding of 
MEK-inhibited tails with DPI treatment (Supplementary Fig. S2), our data indicate a possible involvement of 
ROS in the activation of the MAPK/ERK pathway.
This is supported by literature, as in many of the addressed cellular events modulated by ROS, MAPKs are 
predominantly mentioned as a required intermediate  link22–25,31,49–51. The catabolic cysteine residues, present 
on cytokine receptors and growth factors upstream of the MAPK/ERK pathway as well as on more downstream 
MAPK signaling molecules like MAP3Ks, are generally accepted as critical targets of oxidative stress. Several 
studies demonstrate this link by blocking MAPK signaling after interfering with ROS production or by activat-
ing MAPKs after treatment with exogenous  H2O223–25,52–54. Taking into account that, in planarians, ROS are 
necessary for regeneration and are induced directly after H- and R-wounding, and ERK activation is required 
for regeneration in the same timeframe and location as we observe with ROS production, we further searched 
to determine the functional link between ROS and ERK activation. We demonstrated that after adding exog-
enous  H2O2, MEK-inhibited dormant tails can be rescued without the need to inflict a new wound (Fig. 2). It is 
important to point out that the  H2O2 treatment did not induce visible epidermal wounding, indicating that the 
rescue was not attributed to the re-wounding of dormant tails (Supplementary Fig. S4). We hypothesize that 
because of its relatively long half-life and good membrane permeability, the non-radical ROS,  H2O2, functions 
as a secondary messenger and triggers the activation of important regeneration-related downstream signaling 
processes such as ERK activation. We were not able to show a role for aquaporins in this  H2O2 signaling at the 
initial stage of planarian regeneration. Seven planarian aquaporin genes were identified, but RNAi of the indi-
vidual aquaporins did not result in any defect in regeneration and CNS formation indicating that there could 
be some level of redundancy among them (Supplementary Fig. S6). Unfortunately, there is no current way to 
knockdown all aquaporins simultaneously. In silico analysis did show co-expression of ERK, EGFR-3 and some 
of the aquaporins in neoblasts, neurons and epidermal cells (Supplementary Fig. S7). Also,  H2O2 is able to cross 
cell membranes on its own or via hydrophobic pores induced by configuration changes of oxidized lipids initi-
ated via intra- and intermolecular  processes19,55–57.
The strongly corresponding regeneration impairments (Supplementary Figure S1) when interfering with the 
regeneration-induced ROS burst, or with the ERK  activation17,38, again show an interaction between both events. 
Previously, defects in neoblast differentiation and a significant decrease of the wound-induced expression of 
secreted frizzled related protein 1 (sfrp1) was shown after the inhibition of ROS production and blocking ERK 
 activation17,38. It is believed that the expression dynamics of sfrp1 are regulated by the activity levels of  ERK38,58. 
Together with the strong reduction of ERK activation at the wound site of regenerating animals after inhibition of 
ROS production (Fig. 4), we hypothesize an upstream function of ROS relative to ERK and its ability to activate 
the MAPK/ERK signaling pathway during regeneration initiation. However, we have to take into account that 
MAPK/ERK are activated as a response to many different signals and it cannot be excluded that ROS do not act 
alone but as a part of a more complex initiation signaling  system59,60.
To validate  H2O2 as potential regeneration-initiator, reactivating MAPK/ERK signaling, and to exclude the 
possibility of regeneration rescue due to secondary wounding, we investigated a rather indirect way of rescuing 
regeneration. Instead of direct exposure to exogenous  H2O2, we explored the possibility of using photomodulation 
therapy, in this study referred to as light therapy, which is a widely accepted tool to treat pathological tissues such 
as different wounds to control inflammatory processes, and also to promote tissue  healing32. Photomodulation 
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therapy induces photochemical changes and stimulates stem cell activity by increasing proliferation, migration 
and  differentiation32,33,61. The commonly proposed mechanism behind it is that the absorbed energy of the light 
therapy induces an increased cytochrome c oxidase enzyme activity, electron transportation, oxidative respira-
tion, membrane potential and ATP production, leading to an increased ROS production, cytokines and expres-
sion of growth factors. In turn this can lead to the initiation of several signaling cascades, promoting cellular 
proliferation, migration and  differentiation32–34,62. In many of these studies, it is believed that ROS-stimulated 
MAPK–ERK signaling is one of the important, downstream activated signaling  pathways35. For example, the 
application of light therapy to human keratinocytes, using visible light, leads to ROS-induced phosphorylation 
and subsequently activation of EGFR-ERK signaling  pathway63. However, as indicated by Stubenhaus et al.36, 
exposing S. mediterranea to intense light can lead to ROS production by another mechanism (Supplementary 
Fig. S5a). Intense light exposure causes porphyrin, produced in planarian pigment cells, to generate ROS. ROS 
then drives the oxidation of unoporphyrinogen I, leading to more ROS production, generating a positive feedback 
loop and eventually causing pigment cell  loss36,37. We hypothesized that these ROS can subsequently activate the 
aforementioned MAPK–ERK pathway in exactly the same way. Similar analytical results of porphyrin-induced 
photogeneration of  H2O2 are observed in several in vitro  studies64,65. We achieved a remarkable percentage 
of regeneration rescue, similar to the obtained rescue when treated with exogenous  H2O2 (Fig. 3). After light 
therapy, MEK-inhibited tails strongly depigmented, illustrating the presence and production of ROS as described 
earlier (Supplementary Fig. S5)34–37. This assumption is confirmed by the slight overall presence of ROS, and 
 H2O2 specifically, with a distinguishable and significantly stronger signal of both general ROS and  H2O2 at the 
original dormant R-wound site after light therapy (Fig. 3c). Overall, these results demonstrate light therapy as 
a useful tool in re-initiating regeneration after inhibiting MAPK–ERK pathway and confirm the potential of 
photomodulation as application in regenerative medicine. The exact mechanism, however, remains to be eluci-
dated. Although ROS and  H2O2 are produced directly after inducing regeneration and before the first apoptotic 
peak, we cannot exclude that both exogenous  H2O2 treatment or intense visible light can induce regeneration 
via apoptosis-induced  proliferation66,67.
In many organisms, the epidermal growth factor receptors (EGFR), one of families of the receptor tyrosine 
kinases (RTK), are known to regulate several biological processes by activating key downstream pathways includ-
ing the MAPK  pathway28,29,33,39. In planarians, Smed-egfr-3 is required for proper regeneration as well as for ERK 
activation (Fig. 6b)26. Recent literature. suggested that RTK-associated activation mechanisms are under strict 
redox control. Activation of EGFR signaling by ROS can occur in several  ways30. On the one hand, intracellular 
ROS can facilitate the phosphorylation of EGFR and induce a subsequent cascade of phosphorylation of down-
stream elements. According to Peus and colleagues,  H2O2 specifically acts as a critical mediator in this  case68. The 
absence of ERK activation after inhibition of ROS production (Fig. 4), and the rescue of regeneration in dormant 
tails by either  H2O2 or light therapy in our results support this hypothesis (Figs. 2, 3). Furthermore, silencing 
Smed-egfr-3 results in significantly decreased amputation-induced ROS production, suggesting the dependency 
of ROS production on the EGFR signaling (Fig. 5). This could be explained by the fact that ligand-dependent 
dimerization of EGFR induces ROS production for its autophosphorylation and consequent activation, leading 
to a decreased intracellular ROS production when  silenced30. However, literature also suggests that  H2O2 acts 
as a critical mediator in the ligand-independent phosphorylation and activation of  EGFR68. On the other hand, 
the regulation of NADPH-oxidases (Nox) expression can be controlled by ERK-activation and the subsequently 
activated transcription factors. Knocking down Smed-egfr-3, which led to a decreased ERK activation, could 
therefore alter Nox expression, explaining the impaired ROS  production30,69. However, the involvement of Nox 
genes in planarians still has to be elucidated as no homologues have been identified yet in the current genomic 
and transcriptomic databases. In addition, future research is necessary to further explore and describe these 
feedback mechanisms more in detail.
On the other hand, as MEK is located downstream of EGFR, we would expect a decreased ROS/H2O2 pro-
duction at the wound site after applying wounds in MEK-inhibited tails. However, no significant decrease in 
ROS/H2O2 signal was observed (Fig. 1d). This could be explained by (1) the presence of MEK-independent ROS 
producing mechanisms, as well as (2) the possible occurrence of redundancy. Altogether we propose a signaling 
model of interactions between ROS and the EGFR–MAPK–ERK pathway that is addressed during the earliest 
phase of planarian regeneration. The regulatory pathway suggested here is based on relevant literature on planar-
ians and other systems and is complemented with results presented in this paper (Fig. 6e).
In summary, our results suggest that: (1) ROS and/or  H2O2 have the potential to rescue regeneration in MEK-
inhibited dormant tails, (2) ROS and/or  H2O2 are required for ERK activation at early regeneration stages, (3) 
the EGFR pathway can mediate ROS production with ERK activation during planarian regeneration. We provide 
the first evidence of amputation- and wound-induced ROS/H2O2 production in upstream relationship with the 
EGFR–MAPK–ERK signaling pathway during planarian regeneration in which ROS are not only identified as 
most upstream trigger for regeneration-initiation, but could possibly perform its functions also more down-
stream. In the future, there is a need for next-generation-specific ROS probes that will allow for a better report 
on both location and nature of inter- and intracellular production of specific forms of ROS. This will help in 
exploring the putative role of Noxes, the involvement of aquaporins and the ROS-induced MAPK/ERK activa-
tion, during planarian regeneration. It is necessary to further investigate the relationships of ROS with other 
signaling cascades, which might help in the understanding of how ROS signaling could be manipulated in order 
to improve regeneration in other models and humans.
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Methods
Planarian cultivation. An asexual strain of the freshwater planarian species S. mediterranea was kept in 
Milli-Q water containing 1.2 mM  NaHCO3, 1.6 mM NaCl, 1.0 mM  CaCl2, 1.0 mM  MgSO4, 0.1 mM  MgCl2 and 
0.1 mM KCl. Planarians were continuously maintained in the dark at a temperature of 20 °C. Once a week they 
were fed with veal liver. Animals used in experiments were starved for at least 7 days before the procedure.
Inhibition of reactive oxygen species (ROS) production. The nonspecific flavoprotein inhibitor, 
Diphenyleneiodonium chloride (DPI, Sigma Aldrich, D2926), was used in order to block ROS production by 
interfering with several electron transporters. Animals were exposed to 3 μM DPI for 5 h prior to in vivo ROS 
staining or inflicting a second cut in MEK-inhibited tails, and 1 h prior to amputation when followed by pERK 
immunohistochemistry. In both cases, animals were continuously exposed to DPI during the regeneration 
period. Because of its hydrophobic character, DPI was prepared in 0.01% (v/v) dimethylsulfoxide (DMSO, Sigma 
Aldrich, 471267). In all experiments using DPI, a DMSO-exposed control group was added to take into account 
the possible effects of DMSO since relatively high concentrations can have neurotoxic effects and influence cell 
proliferation in S. mediterranea70.
MEK inhibition. The chemical compound PD0325901 (Calbiochem) was used to reversibly inhibit MEK 
activity and subsequently prevent the activation of ERK. As a consequence, we obtained dormant planarian 
fragments as described by Owlarn et al.14. PD0325901 was dissolved in DMSO and used in a concentration of 
25 μM. Planarians were exposed to PD0325901 for 1 h prior and up to 5 to 7 days post amputation. The exposure 
solution was replaced daily. After treatment with PD0325901, animals were gently washed and placed in fresh 
medium.
H2O2 treatment. Dormant, MEK-inhibited fragments were exposed to  H2O2 (Sigma Aldrich, 30% (v/v) 
in water) with the intention to rescue regeneration. After initial range finding experiments, fragments were 
exposed to either 1.5 mM (0.005%) or 2.25 mM (0.0075%)  H2O2 (in cultivation medium) for 6 h. Afterwards 
they were washed for 3 times and kept in fresh medium. All treated samples were handled very carefully in order 
to prevent wounding.
Light therapy. MEK-inhibited tail fragments were treated with light therapy in order to investigate the 
possibility of rescuing regeneration at the original applied R-wound. After initial trail experiments using differ-
ent wavelengths, the full spectrum of visible light (VIS) was used for the therapy. SCHOTT KL 1500 lcd with 
a halogen lamp, color temperature of 2950 K and light intensity of 6.500 lx was used to apply light therapy to 
the MEK-inhibited fragments. Samples were treated with VIS light for two times 1 h each separated by 1 h of 
recovery in full darkness. Control animals were kept in the dark. Light intensity was measured using the LI-COR 
quantum/radiometer/photometer (model LI-189), in exactly the same experimental setup as used for the light 
therapy. All treated samples were handled very carefully in order to prevent wounding.
RNA interference. Double-stranded RNA (dsRNA) for Smed-egfr-3 and Smed-aqp-(1–7) were synthesized 
as previously described (Smed-egfr-3, forward primer: GTA CTG GGC AAT GTT GGA CCT GGC , reverse primer: 
TGA CGG CCT CAT GTG GGG ATC ATC G; Smed-aqp-1, forward primer: GCA GAA CTT CTT GGC ACC TT, 
reverse primer: CCC ACT ATT GGT ATC ATG GC; Smed-aqp-2, forward primer: TTT TGG TTG TCA GTG GTC 
GC, reverse primer: CGG AAG AGG GAA AAC TGA CG; Smed-aqp-3, forward primer: TTG CCT CAA TCG GTC 
GTT TG, reverse primer: ATG CTC CGA AAA CTC CTC CA; Smed-aqp-4, forward primer: CGT GGG TCC AAT 
TTC AGG , reverse primer: GGG TAC TTT CTA TTC GTG AAG; Smed-aqp-5, forward primer: GAC ACA TCA 
ATC CAG CCG TC, reverse primer: CGT CAT ACC GAT CAG CCT TT; Smed-aqp-6, forward primer: CGT TGA 
ATT CCT AGG AAC TTTC, reverse primer: GCC ACA ATG TTG AGC AAT GAC; Smed-aqp-7, forward primer: 
TTC CCT TCA CCA ACA GCA GG, reverse primer: CCG TGA GCA ACG GCA ACG GC). Animals were injected in 
two rounds of 3 consecutive days each with 4 days elapsed in between. On day 4 of the second round, planarians 
were amputated pre- and post-pharyngeally to induce regeneration. Injections were done using the Nanoject 
II (Drummond Scientific, Broomall, PA, USA) and consisted of three times 32 nl containing 1 μg/μl  dsRNA71. 
Controls were injected with dsRNA of gfp.
Morphological characterization. The effects of DPI,  H2O2 treatment or light therapy on the ability to 
restore the regenerative capacity after reversible MEK-inhibition were studied by measuring differences in blas-
tema sizes 7 days post re-cutting (2nd cut) or treatment, compared with MEK-inhibited controls without any 
treatment. In case of DPI treatment, blastema sizes were measured on day 10 post re-cutting. Blastema areas 
were quantified using ImageJ (version 1.48v) on digital micrographs acquired with a Nikon DS-Ri2 digital cam-
era mounted on a Nikon SMZ800 stereomicroscope. The blastema area measurements were normalized against 
the total body area of the worm. These worms were also scored according to their photoreceptor (eye) develop-
ment. Therefore, the presence of the eyes (2, 1 or 0 eyes) on 7 or 10 days post re-cutting/treatment was recorded.
Immunohistochemistry. To analyze the relationship between ROS and Smed-egfr-3 relative to ERK acti-
vation in early regeneration, a pERK immunostaining was performed after interfering with the aforesaid. Pla-
narians were fixed at 6 and/or 24 h of regeneration and processed as previously  described26. Bleached animals 
were washed with PBSTx (1 × PBS (10 × PBS: 1.37 M NaCl, 27 mM KCl, 100 mM Na2HPO4, 20 mM KH2PO4 
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in ultrapure  H2O), 0.3% (v/v) Triton X-100) and incubated for 4 h in 1% blocking solution (1% (w/v) BSA in 
PBSTx) followed by the primary antibody (anti-pERK) diluted 1/1000 in blocking solution) overnight at 4 °C.
The immunostainings with anti-phospho-histone 3, anti-SYNAPSIN and anti-arrestin VC1 were carried out as 
described  previously72. We used anti-phospho-histone3 (PH3, Cell signalling technology) to detect mitotic cells 
(diluted 1/300); anti-SYNAPSIN used as a pan-neural marker (diluted 1/50, Developmental Studies Hybridoma 
Bank)73; and, anti-VC-1, arrestin (VC-1, a mouse antibody specific for planarian photosensitive cells (1:15,000)74. 
After PBSTx washes and 1 h in blocking solution, they were incubated with the secondary antibody (goat anti-
rabbit-POD diluted 1/500 in blocking solution) overnight at 4 °C. After PBSTx washes, samples were incubated 
for 8 min in TSA Plus Fluorescein solution (1/50 TSA Plus Fluorescein in 1 × Amplification Buffer (Tyramide 
Signal Amplification Labeling Kit No. 2; Molecular Probes, Thermo Fisher Scientific) in darkness. Samples were 
mounted after the final PBSTx washes (RT) and analysed with a MZ16F fluorescence stereomicroscope (Leica) 
equipped with a ProgRes C3 camera (Jenoptik, Jena, Germany).
Fluorescence intensity measurements of general ROS-,  H2O2- or pERK signal. The relative fluo-
rescence intensities of samples with an in vivo general ROS or  H2O2 staining as well as samples with a pERK 
immunostaining, were quantified using ImageJ (version 1.48v) on images taken with a MZ16F fluorescence 
stereomicroscope (Leica) equipped with a ProgRes C3 camera (Jenoptik, Jena, Germany). The mean intensity 
values were obtained for anterior and/or posterior blastema regions in case of the pERK immunostaining (FI-
Blastema). When carried out an in  vivo ROS/H2O2 stain, the mean intensity values were obtained from the 
H- and R-wound region (FI-Wound). In both cases, the background mean pixel intensity values were obtained 
(FI-Background; average of 3 distinct regions in the rest of the fragment, except the region at the ventral nerve 
cords and photoreceptors as there is a stronger pERK specific signal). The fluorescence intensity was expressed 
as the mean FI-Blastema or FI-Wound divided by the mean FI-Background, representing how many times the 
signal in the blastema or wound region is higher compared with the background.
In vivo general reactive oxygen species (ROS) detection. The compound 5-(and-6)-carboxy-2′,7′-
dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA, Image-iT LIVE Green Reactive Oxygen Species 
Detection Kit, Molecular Probes; Invitrogen, I36007) was used to visualize the general in vivo production of 
ROS, in which fluorescent carboxy-DCF is produced through ROS oxidation after removal of the acetate groups 
by intracellular esterases. The ROS visualization procedure was performed on Smed-egfr-3 RNAi knockdown 
animals as well as control- and MEK-inhibited animals either combined or not with the inhibition of ROS 
production by DPI or light therapy. Animals were exposed to carboxy-H2DCFDA (25 μM, 1 ml) for 1 h prior 
to amputation and for 1 day post RNAi. Amputated animals were again incubated in carboxy-H2DCFDA for 
15 min before immobilization in 2% (w/v) low melting point (LMP) agarose (Invitrogen, 16520-050). Imaging of 
the samples was performed on 30 min, 6- and/or 24 h post amputation (MPA/HPA) using a MZ16F fluorescence 
stereomicroscope (Leica) combined with a ProgRes C3 camera (Jenoptik, Jena, Germany) or a Ts2-FL inverted 
microscope (Nikon) combined with a Ds-Fi3 color camera (Nikon). For all pictures the exact same capturing 
settings were used. Additionally, all experiments were also performed without the carboxy-H2DCFDA-stain in 
order to discard possible autofluorescence at the wound sites.
In vivo  H2O2 detection. The compound 2′,3′,6′,7′-Tetrahydro-12′-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)-spiro[isobenzofuran-1(3H) or Peroxy Orange 1 (PO1, Sigma-Aldrich, SML0688) was used to specifically 
stain in vivo, intracellular  H2O2. After initial range finding experiments, worms were incubated for 1 h in 20 μM 
PO1 working solution (stock- in DMSO, working solution in fresh cultivation medium) prior to (re)wounding 
depending on the experimental setup. After amputation, samples were followed by another 15 min incubation 
in the same staining solution. Next, worms were gently rinsed with medium and imaged using a fluorescent 
microscope (Nikon Eclipse 80i) with a Nikon DS-Ri2 digital camera. For all pictures the exact same capturing 
settings were used. Additionally, all experiments were also performed without the PO1-stain in order to discard 
possible autofluorescence at the wound sites.
Statistical analysis. Data was analyzed using a one- or two-way ANOVA followed by a Tukey HSD post-
hoc test for multiple comparisons. Normality was checked by Shapiro–Wilk, followed by a transformation of the 
data set (ex, 1/x, Square root and Log) if the assumptions of normality were not met. All analyses were performed 
with RStudio 0.98.1103 (Rstudio, Inc.) p values < 0.05 were considered significant.
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